Kasi, P. M., Baron, A. D., Chaudhry, A., Tenner, L. L., Vijayvergia, N., Driscoll, M. F., Adams, D. L., Duffy, A. B., Rui, H., Pestell, R. G., Vittner, P. J., Meidling, J., Lalezari, J. P. (2026). Leronlimab in combination with trifluridine/tipiracil (TAS-102) plus bevacizumab for patients with refractory metastatic colorectal cancer (mCRC): The phase 2 CLOVER study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15525